Lords take a shine to patent

An appeal by Biogen in its battle with Medeva over genetic engineering patents involving treatment for Hepatitis B virus is now in the list of pending cases before the Lords. Questions of inventiveness, disclosure and the extent to which a patent needs to be looked at as a whole will be considered.